Observational Study of Baska Mask, a New Supraglottic Airway Device in Children

May 28, 2014 updated by: John Laffey
The investigators wish to accumulate initial data on the performance and safety of the Baska mask in paediatric patient population.

Study Overview

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Galway, Ireland
        • Galway University Hospitals

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

8 years to 16 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • consent
  • BMI 15-35
  • weight over 30kg or age 8-16 yrs
  • non-urgent surgery of planned duration up to 2 hrs

Exclusion Criteria:

  • neck pathology
  • previous or anticipated problems with the upper GI or upper airway
  • increased risk of gastric aspiration
  • expected difficult airway

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Baska mask
Use of Baska mask as a supraglottic airway during general anesthesia

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Device insertion success rate
Time Frame: within 30 minutes of induction of general anesthesia
within 30 minutes of induction of general anesthesia
device airway leak pressure
Time Frame: within 10 minutes of successful device placement
the airway l;eak pressure is defined as the plateau airway pressure measured while the patient is apnoeic with the APL valve of the anaesthetic machine set to 35 cm H2O and the fresh gas flow set to 6 L/min
within 10 minutes of successful device placement

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
airway stability
Time Frame: within 30 minutes of device placement
the tidal volumes will be measured in different head positions and the leak fractions calculated.
within 30 minutes of device placement
ease of device placement
Time Frame: within 30 minutes of induction of general anesthesia
the ease of device placement will be evaluated by Visual Analogue Scale
within 30 minutes of induction of general anesthesia
complications during the anesthetic
Time Frame: from the start of device insertion untill discharge from recovery, an expected average of 2 hours
complications that may be related to the device use will be monitored including but not limited to desaturation episodes, laryngospasm, loss of airway, need to switch ot alternative device, blood staining on mask removal sore throat, dysphonia, dysphagia
from the start of device insertion untill discharge from recovery, an expected average of 2 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Michael Scully, FFARCSI, UCHG

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2012

Primary Completion (Actual)

June 1, 2013

Study Completion (Actual)

June 1, 2013

Study Registration Dates

First Submitted

March 23, 2012

First Submitted That Met QC Criteria

June 18, 2012

First Posted (Estimate)

June 21, 2012

Study Record Updates

Last Update Posted (Estimate)

May 29, 2014

Last Update Submitted That Met QC Criteria

May 28, 2014

Last Verified

May 1, 2014

More Information

Terms related to this study

Other Study ID Numbers

  • C.A.657

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Baska Mask Efficacy and Safety in Children

Clinical Trials on Placement and use of Baska mask

3
Subscribe